栄研化学(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4549/E00961-
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2023/03/03日証協無担保2,400株-91.97%0株0%1,103株-21.38%
2023/03/03日証協有担保126,685株+67.43%7,223株+67.98%112,369株-31.51%
2023/02/24日証協無担保29,900株0%0株0%1,403株-59.97%
2023/02/24日証協有担保75,663株+92.7%4,300株-94.75%164,074株+195.43%
2023/02/17日証協無担保0株-100%0株0%3,505株-28.53%
2023/02/17日証協有担保39,264株-19.95%81,934株+85.94%55,537株-60.22%
2023/02/10日証協無担保600株0%0株0%4,904株-19.67%
2023/02/10日証協有担保49,050株-59.49%44,065株+155.88%139,626株-28.81%
2023/02/03日証協無担保0株0%0株0%6,105株+204.95%
2023/02/03日証協有担保121,068株-58.64%17,221株+34.41%196,119株+60%
2023/01/27日証協無担保0株-100%0株0%2,002株-33.62%
2023/01/27日証協有担保292,691株-39.69%12,812株+700.75%122,574株+3.32%
2023/01/20日証協無担保21,500株0%0株0%3,016株-18.79%
2023/01/20日証協有担保485,300株-32.32%1,600株-70.91%118,637株+16.09%
2023/01/13日証協無担保0株-100%0株0%3,714株-43.14%
2023/01/13日証協有担保717,100株-16.97%5,500株+2650%102,195株-26.81%
2023/01/06日証協無担保11,000株+3566.67%0株0%6,532株+444.33%
2023/01/06日証協有担保863,692株+56.32%200株0%139,633株-10.7%
2022/12/30日証協無担保300株0%0株0%1,200株-65.22%
2022/12/30日証協有担保552,500株-68.15%200株-33.33%156,372株-46.93%
2022/12/23日証協無担保0株0%0株0%3,450株+72.5%
2022/12/23日証協有担保1,734,737株+2149.98%300株-99.57%294,654株+75.72%
2022/12/16日証協無担保0株0%0株0%2,000株+33.33%
2022/12/16日証協有担保77,100株+177.34%69,000株+422.73%167,688株+22.19%
2022/12/09日証協無担保0株-100%0株0%1,500株-59.47%
2022/12/09日証協有担保27,800株+139.9%13,200株-53.36%137,230株+145.37%
2022/12/02日証協無担保800株-98.31%0株0%3,701株-86.14%
2022/12/02日証協有担保11,588株-87.72%28,300株0%55,927株+48.93%
2022/11/18日証協無担保3,800株0%0株0%1,406株+368.67%
2022/11/18日証協有担保29,816株-72.78%18,900株-41.23%127,190株+14.94%
2022/11/11日証協無担保0株0%0株0%300株-75%
2022/11/11日証協有担保109,538株+10.81%32,162株+73.77%110,660株-38.96%
2022/11/04日証協無担保0株-100%0株0%1,200株-52%
2022/11/04日証協有担保98,852株-8.43%18,508株-75.02%181,294株+240.86%
2022/10/28日証協無担保16,000株+10.34%0株0%2,500株+56.25%
2022/10/28日証協有担保107,952株-28.03%74,100株-8.41%53,187株-13.23%
2022/10/21日証協無担保14,500株+222.22%0株0%1,600株+33.33%
2022/10/21日証協有担保149,998株-28.17%80,900株+212.36%61,300株-76.67%

※株式分割は考慮していませんのでご注意ください。

Page Top